Search filters

List of works by Catalina Abad

Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock

scientific article published on 20 January 2005

Anti-inflammatory actions of VIP/PACAP. Role in endotoxemia

scientific article published on 01 January 2000

Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock

scientific article published on 01 November 2000

Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

scientific article

Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.

scientific article published in July 2006

Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease

scientific article

Immunology of VIP: a review and therapeutical perspectives.

scientific article

Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice

scientific article published on 13 August 2018

Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis.

scientific article published on January 2011

Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

scientific article

Impairment of axotomy-induced pituitary adenylyl cyclase-activating peptide gene expression in T helper 2 lymphocyte-deficient mice

scientific article published in February 2006

Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice

scientific article published in January 2004

Lymphocyte regulation of neuropeptide gene expression after neuronal injury

scientific article published in October 2003

Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death.

scientific article published on 20 May 2008

Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway

scientific article

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases

scientific article published on 22 October 2019

PAC1 receptor: emerging target for septic shock therapy

scientific article published on 01 July 2006

Pituitary adenylate-cyclase-activating polypeptide expression in the immune system

scientific article published in January 2002

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.

scientific article

Regulation of VIP production and secretion by murine lymphocytes

scientific article published on 01 January 1999

Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+ T-lymphocytes

scientific article published in December 2004

Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide

scientific article published on 01 September 1999

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

scientific article published on 20 March 2019

Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma

scientific article published on 25 September 2013

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

scientific article published in April 2003

Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.

scientific article published on 27 April 2005

VIP decreases TLR4 expression induced by LPS and TNF-alpha treatment in human synovial fibroblasts

scientific article published on 01 July 2006

VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses

scientific article

VIP in inflammatory bowel disease: state of the art.

scientific article published on December 2012

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.

scientific article

Vasoactive intestinal peptide as a healing mediator in Crohn's disease.

scientific article published on 29 July 2008

Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids

scientific article published on 19 June 2008

Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.

scientific article

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

scientific article published on 01 May 2001

Vulnerability imposed by diet and brain trauma for anxiety-like phenotype: implications for post-traumatic stress disorders

scientific article

cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.

scientific article published in July 2005

Paulina is supported by:

About Paulina

Help